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Abstract
Background: Declined lung function is a risk factor for particulate matter associated respiratory diseases like
asthma and chronic obstructive pulmonary disease (COPD). Carbon nanoparticles (CNP) are a prominent
component of outdoor air pollution that causes pulmonary toxicity mainly through inflammation. Recently we
demonstrated that mice (C3H/HeJ) with higher than normal pulmonary function resolved the elicited pulmonary
inflammation following CNP exposure through activation of defense and homeostasis maintenance pathways. To
test whether CNP-induced inflammation is affected by declined lung function, we exposed JF1/Msf (JF1) mice with
lower than normal pulmonary function to CNP and studied the pulmonary inflammation and its resolution.
Methods: 5 μg, 20 μg and 50 μg CNP (Printex 90) were intratracheally instilled in JF1 mice to determine the dose
response and the time course of inflammation over 7 days (20 μg dosage). Inflammation was assessed using
histology, bronchoalveolar lavage (BAL) analysis and by a panel of 62 protein markers.
Results: 24 h after instillation, 20 μg and 50 μg CNP caused a 25 fold and 19 fold increased polymorphonuclear
leucocytes (PMN) respectively while the 5 μg represented the ‘no observable adverse effect level’ as reflected by
PMN influx (9.7 × 10E3 vs 8.9 × 10E3), and BAL/lung concentrations of pro-inflammatory cytokines. Time course
assessment of the inflammatory response revealed that compared to day1 the elevated BAL PMN counts (246.4 ×
10E3) were significantly decreased at day 3 (72.9 × 10E3) and day 7 (48.5 × 10E3) but did not reach baseline levels
indicating slow PMN resolution kinetics. Strikingly on day 7 the number of macrophages doubled (455.0 × 10E3 vs
204.7 × 10E3) and lymphocytes were 7-fold induced (80.6 × 10E3 vs 11.2 × 10E3) compared to day1. At day 7
elevated levels of IL1B, TNF, IL4, MDC/CCL22, FVII, and vWF were detected in JF1 lungs which can be associated to
macrophage and lymphocyte activation.
Conclusion: This explorative study indicates that JF1 mice with impaired pulmonary function also exhibits delayed
resolution of particle mediated lung inflammation as evident from elevated PMN and accumulation of
macrophages and lymphocytes on day7. It is plausible that elevated levels of IL1B, IL4, TNF, CCL22/MDC, FVII and
vWF counteract defense and homeostatic pathways thereby driving this phenomenon.
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A major component of urban air pollution is particulate
matter (PM). Various epidemiological and clinical studies
have shown the correlation between ambient PM con-
centration and adverse respiratory health effects through-
out the developing countries and the industrialized
world. Exposure to PM has been associated with an
increased risk of various respiratory and cardiopulmonary
diseases, increased mortality, and emergency room visits
due to respiratory problems and restricted lung function
[1-3]. Interestingly, several studies show that individuals
with poor pulmonary function are expected to be at
higher risk to respiratory diseases [4-6] like asthma or
chronic obstructive pulmonary disease (COPD). Carbon
black is an ingredient in rubber, plastics, inks and paints
with an annual production of 10 million tons [7] indicat-
ing its wide usage and potentially massive exposure in
day to day life among people of various working class.
Carbon nanoparticles (CNP) also constitutes the core of
combustion derived particles [8] and represents relevant
surrogates for exhaust particles from modern diesel
engines [9,10].
Inflammatory responses, triggered by pro-oxidative par-
ticle properties, are considered to attribute significantly to
chronic pulmonary disease processes, such as COPD.
Beside exposure to cigarette smoke, traffic and domestic
heating as well as indoor house cooking are major sources
of local combustion related particle exposures [11,12]. In
this context ultrafine carbon particles are an important
component of air pollution with respect to particle num-
ber and surface area. An increasing use of engineered
nanoparticles in all spheres of life makes CNP also an
evolving source of human exposure [13]. CNPs regardless
of their different sources exhibit properties not displayed
by their macroscopic counterparts. The high pulmonary
deposition efficiency along with their large specific surface
area, ready to interact with biological material and their
potential to evade lung clearance by entering pulmonary
cells is considered to be important in driving the emerging
health effects of CNP linked to respiratory toxicity [14,15].
Previously C3H/HeJ (C3) and JF1/Msf (JF1) were
detected to be the most divergent inbred mouse strains
based on a pulmonary function screen [16-18]. For
example, JF1 mice have smaller and less compliant
lungs with larger conducting airway volumes compared
to C3 mice. Therefore to approach experimentally the
epidemiological finding of higher susceptibility for
respiratory diseases among individuals with lower basal
pulmonary function we have selected JF1, a strain pre-
viously characterized for limited pulmonary function as
the physiological base [16-18] and physically-chemically
well characterized, endotoxin free moderately toxic car-
bon nanoparticles (Printex 90) as the toxicological base
in this study [19,20]. Through this broad explorative
study our prime aim was to identify the potentially
important molecular events taking place during the
acute inflammatory response and its resolution following
CNP exposure in JF1 mice and to compare the response
to that of recently assessed in C3 mice, a strain with
higher basal pulmonary function [21].
Methods
The experiments were carried out using identical meth-
odology as previously described by Ganguly et al [21].
Particles
For CNP instillation endotoxin free Printex 90 particles
obtained from Degussa (Frankfurt, Germany) were used as
described earlier [21]. The primary particle size of Printex
90 is 14 nm, the specific surface area about 300 m
2/g, and
the organic content low, 1-2% [20]. Vials of 5 μg, 20 μg
and 50 μg CNP particles in 50 μl were prepared just before
use by suspending in pyrogen-free distilled water (Braun,
Germany). The suspension of particles was sonicated on
ice for 1 min prior to instillation, using a SonoPlus HD70
(Bachofer, Berlin, Germany) at a moderate energy of 20
Watt. We favor the use of distilled water for suspension of
particles because the salt content of phosphate-buffered
saline (PBS) causes rapid particle aggregation comparable
to the “salting-out” effect and thus eliminates consistent
instillation conditions. Particle characteristics have been
described previously [21]. Briefly, The Zeta potential and
intensity weighted median dynamic light scattering dia-
meter of the printex 90 particles in a pyrogen free distilled
water suspension at a concentration of 20 μg/50 μlu s i n g
Zetatrac (Model NPA151–31A; Particle Metrix GmbH,
Meerbusch, Germany) was 33 mV and 0.17 μm
respectively.
Mouse procedures
Animals
This study was approved by the Bavarian Animal Research
Authority (Reference No: 55.2-1-54-2531-115-05). Female
JF1/Msf (JF1) animals were purchased from the Jackson
Laboratories (Bar Harbour, ME USA) at the age of 8
weeks. The animals were housed and acclimatized at the
animal facility of Helmholtz Zentrum München under
specific pathogen free conditions according to the Eur-
opean Laboratory Animal Science Association Guidelines
[22] for at least 4 weeks. Food and water were available ad
libitum. The experiments were performed with 12-14
weeks old animals. Mean body weight was 14.3 ± 1.7 g
(mean ± SEM). Experimental groups were age matched
and the age of 12-14 weeks was considered for this study
so as to exclude the effect of any lung developmental
events that may interfere with susceptibility. By the age of
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lung is fully grown and has a mature structure [23].
Mice were anesthetized by intraperitoneal injection of a
mixture of xylazine (4.1 mg/kg body weight) and ketamine
(188.3 mg/kg body weight). The animals were then intu-
bated by a nonsurgical technique [24]. Using a bulbheaded
cannula inserted 10 mm into the trachea, a suspension
containing 5, 20, or 50 μg CNP (Printex90) particles,
respectively, in 50 μl pyrogene-free distilled water was
instilled, followed by 100 μl air. Animals were treated
humanely and with regard for alleviation of suffering.
Experimental design
Seven experimental groups were selected which included
cage control, sham (vehicle) exposed, and CNP exposed
(5 μg/day1, 20 μg/day1, 20 μg/day3, 20 μg/day7, 50 μg/
day1) by intratracheal (i.t.) instillation. Cage control ani-
mals were not instilled, and sham animals received 50 μl
pure distilled water (vehicle). The animal groups were
designed so as to obtain an acute dose-response relation-
ship [5 μg/day1, 20 μg/day1 and 50 μg/day1] and also to
get a time course response [20 μg/day1, 20 μg/day3,
20 μg/day7] following i.t. instillation. Therefore 5 groups
were exposed to particles and 2 groups served as control
(cage control and sham exposed). Each of the seven
experimental groups consisted of 11 animals (7 for lavage
and 4 for histopathology) based on our previous experi-
ences [21]. Out of the 7 lavaged animals, tissue samples
from 4 mice were collected for protein analysis and 3 for
future RNA studies. Four non-lavaged animals were used
for histopathology. Lavaged lungs were immediately frozen
in liquid nitrogen following dissection and stored at -80°C
until next procedures for molecular analysis.
Bronchoalveolar lavage (BAL) and analysis
On day1/day3/day7 (as per experimental design) after
instillation, mice were anesthetized by intraperitoneal
injection of a mixture of xylazine and ketamine and sacri-
ficed by exsanguination. BAL was performed accordingly
(i.e. day1/day3/day7 after instillation) by cannulating the
trachea and infusing the lungs 10 times with 1.0 ml PBS
without calcium and magnesium, as described previously
[21]. The BAL fluid from lavages 1 and 2 were pooled and
centrifuged (425 g, 20 min at room temperature). The cell-
free supernatant from lavages 1 and 2 were pooled and
stored at -20°C immediately for biochemical measure-
ments such as total protein and panel assays. The cell pel-
let from lavages 1 and 2 was resuspended immediately in
1 mL RPMI 1640 medium (BioChrome, Berlin, Germany)
and supplemented with 10% fetal calf serum (Seromed,
Berlin, Germany); the number of living cells was deter-
mined by the trypan blue exclusion method. We per-
formed cell differentials on the cytocentrifuge preparations
(May-Grünwald- Giemsa staining; 2 × 200 cells counted).
We used the number of polymorphonuclear leukocytes
(PMNs) as a marker of inflammation. Total protein
content was determined spectrophotometrically at
620 nm, applying the Bio-Rad Protein Assay Dye Reagent
(no. 500-0006; BioRad, Munich, Germany). We analyzed
50 μl BAL/mouse for panel assays.
Histology
Four not lavaged animals per experimental group were
used for histological analysis. Mice were sacrificed by an
overdose of ketamin and the lungs were inflation-fixed at
a pressure of 20 cm H2O by instillation of phosphate buf-
fered 4% formaldehyde. Three cross slices of the left lobe
and 4 slices of each right lobe were systematically selected
and embedded in paraffin, and 4 μmt h i c ks e c t i o n sw e r e
stained with hematoxylin and eosin. The sections were
then studied by light microscopy.
Protein panel assays
In this study we analyzed the identical set of 62 protein
markers as already introduced while studying CNP expo-
sure in C3 mice [21]. A detailed list of each of the 62 mar-
kers, their gene symbol and associated gene ontology
terms, least detectable dose (LDD) etc. is supplied in Addi-
tional File 1, Table S1. Our panel of markers are known to
play important roles in the following key processes of lung
tissue: i) Initiation and amplification of inflammation ii)
Induction of T-cell independent macrophage activation
iii) Regulation of dendritic cell maturation and differentia-
tion, and iv) Regulation of T-cell activation and differen-
tiation as described by [25].
Total lung homogenate was prepared using 50 mM
Tris-HCL with 2 mM EDTA, pH 7.4 as the lysis buffer
(1000 μl) from 4 animals/experimental group using the
whole lung. Using the Rodent MAP™ version 2.0 of the
Rules Based Medicine (Austin, Texas) a panel of mostly
proinflammatory and inflammatory markers was analyzed
from total lung homogenate and BAL. BAL and lung
homogenates were always taken from the same animals to
avoid any inter-animal variation. BAL of the 4 animals/
group was pooled for the measurement and only the mar-
kers equal to/above (≥) the sensitivity level were consid-
ered. BAL was pooled from 4 animals as our focus was on
the lung homogenate considering BAL concentrations of
proteins are often below LDD. Sensitivity level was the
LDD as provided by Rules Based Medicine. We considered
in pooled samples the markers below sensitivity levels to
be not reliable due to lack of scope for reproducibility in
multiple independent samples. However, in the lung
homogenate markers below LDD were also considered for
analysis and discussion as we could measure samples from
4 independent animals/group. In most cases little variance
between replicates was observed.
A d d i t i o n a l l yt h r e em o r em a r k e r sh e m o x y g e n a s e - 1
(HO-1; Stressgen Catalog # 960-071), osteopontin
(SPP1; Stressgen Catalog # 900-090A) and lipocallin-2
(LCN2; R&D Systems Catalog # DY1857) were assayed
from the same samples using the respective ELISA kits.
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Protein expression data from lung tissue (means, n = 4)
and BALF (pools from 4 animals) were used for heat-
map generation. Protein concentrations were normalized
to the highest value for each protein (set to equal 1) and
the resulting values were used as input for heatmap gen-
eration with CARMAweb [26]. The Ingenuity Pathway
Analysis tool was used to generate the interaction net-
work for selected regulated proteins and to identify their
biological functions.
Statistics
A two-way analysis of variance (ANOVA) was used to
analyze differences between control and various exposure
groups. P values less than 0.05 were considered as statis-
tically significant. All computations were done by the
software packages Statgraphics plus v5.0 (Manugistics,
Rockville, MD) and SAS V9.1 (Cary, NC). All the data
were normally distributed (F-test). Data are presented as
arithmetic mean values of n observations ± the standard
error (SE).
Results
The exposure groups were designed to assess an acute
dose-response relationship one day after intratracheal instil-
lation of 5 μg (0.35 g/kg BW), 20 μg( 1 . 4g / k gB W )a n d
50 μg Printex 90 (3.5 g/kg BW). The time course response
was obtained for the moderate dose of 20 μg/mouse lung
on day 1, day 3 and day 7. We have not observed any signif-
icant difference between cage control and sham exposed
control animals in any of the measurements performed
using BAL and lung homogenate.
Dose and time response of BAL cells
The total number of retrieved BAL leucocytes was not
affected after i.t. instillation of 5 μg CNP (0.27 ± 0.04 ×
10E6 cells/lung versus 0.27 ± 0.05 × 10E6 cells/lung in
sham exposed mice) but increased two fold to 0.53 ±
0.06 × 10E6 cells/lung at day 1 (p < 0.05) after instillation
of 20 μg CNP (data not shown). The time course analysis
revealed an intermittent decline of BAL leucocytes almost
to control level on day 3 (0.31 ± 0.07 × 10E6 cells/lung,
n.s.) followed by an increase to 0.51 ± 0.11 × 10E6 cells/
lung on day 7, i.e. to 188% of that observed in sham
exposed mice.
PMN
As observed for the total cell count no significant induc-
tion of PMN was detected following i.t instillation of 5 μg
CNP (8.9 ± 2.3 × 10E3 PMNs) compared to control (9.7 ±
1.5 × 10E3 PMNs, Figure 1a). The increase of PMN num-
bers detected on day1 after 20 μgo r5 0μg CNP instillation
already reached saturation at the 20 μg dosage. A 25-fold
induction of PMN was detected following 20 μg( 2 4 6±5 8
× 10E3 PMNs) and a 19-fold after 50 μg (182 ± 31 × 10E3
PMNs) CNP instillation. Time course analysis of PMN
numbers revealed significantly reduced PMN counts after
3 days (73.9 ± 22.1 × 10E3 PMNs) and 7 days (48.5 ± 27.4
× 10E3 PMNs) compared to that of day1. However at day
3 and day 7 the PMN count remained 8 and 5 times
higher (< 0.05), respectively, than the baseline values indi-
cating incomplete resolution of the neutrophil influx
related inflammation following 20 μg of CNP instillation.
Macrophages
No dose dependent increase of macrophage numbers
was observed (Figure 1b). Strikingly, in the time course
analysis an obvious, 1.8-fold induction of macrophage
numbers was detected at day 7 (455 ± 83 × 10E3, vs.
sham 257 ± 48 × 10E3, p < 0.05).
Lymphocytes
The acute response of lymphocytes on day 1 is to some
extent comparable to that of PMNs showing the highest
influx with the 20 μgb u tn o ta tt h e5 0μg dosage (Fig-
ure 1c). Strikingly, in the time course analysis a moder-
ate induction of lymphocyte numbers in response to 20
μg CNP was detected on day 1 (4.9 times) and day3 (7.6
times) followed by a strong induction of lymphocyte
numbers being detected on day 7 (35.1 times). It is
interesting to note that the time course response of lym-
phocytes resembles that of the macrophages as both cell
types show a maximum influx at day 7.
BAL protein concentration
Compared to sham exposed mice, only the instillation of
the highest dose (50 μg/mouse) caused a significant (2.1
fold) increase in total BAL protein concentration (131.5
± 14.5 μg/ml versus 280.1 ± 8.3 μg/ml, p < 0.05) 1 day
after CNP instillation indicating alveolar barrier injury
with capillary leakage only at this concentration (Figure
1d). Time course investigation of 20 μgi n s t i l l e dl u n g s
revealed no changes of BAL protein concentrations
from day 1 to day 3 and day 7.
Histopathology
Histopathological analysis of paraffin embedded JF1 lung
sections (n = 4) showed a typical dose dependent accu-
mulation of particle laden macrophages on days 1, 3
and 7 (Figure 2a-e). In 50 μg/day1 samples inflammatory
cell infiltration (PMN) was clearly visible (Figure 2e)
whereas at 20 μg/day1 only slight PMN infiltration was
detectable (data not shown).
Molecular analysis for lung and BAL compartment
In the present study a panel of 62 protein markers was
applied to assess the CNP response in JF1 mice as
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each of the 62 markers is supplied in Additional File 1,
Table S1.
Lung compartment
From the 62 markers 17 proteins did not exhibit any
response in lung and were therefore not considered for
analysis (CD40, CRP, EDN1, FGF9, F3, haptoglobin,
IgA, IL17, IL2, SAP, SCF, SGOT, TF, HO-1, GST-a,
myoglobin, VCAM1). Dose and time course responses
of the remaining 45 proteins are represented as a heat
m a pi nF i g u r e3 .I nt h eC N Pd o s er e s p o n s em o s tp r o -
teins showed a strong upregulation already at a dose of
20 μga n dt h ee x p r e s s i o nl e v e lo f1 4o ft h e md i dn o t
significantly increase further at a dose of 50 μg( F 7 ,
FGA, GCP2/CXCL5, MCP1/CCL2, MCP3/CCL7,
MCP5/CCL12, IP10/CXCL10, KC/CXCL1, MDC/
CCL22, MIP1b/CCL4, MIP2/CXCL2, MIP1g/CCL9,
THPO and vWF). This observation can be associated
with the dose response of PMN numbers in the BAL as
these proteins include the major PMN recruiters
CXCL1, 2, 5 and 10. From the 45 proteins 13 proteins
were not significantly regulated at 20 μg/day1 but were
significantly induced at 50 μg/day1 (APOA1, CD40L,
EGF, FGF2, IFN-gamma, IL18, IL1B, IL3, IL4, IL5, M-
CSF/CSF1, MIP1a/CCL3, and RANTES/CCL5).
F o rt h et i m ec o u r s es t u d yt h em a j o r i t yo fp r o t e i n s
exhibited the expected response pattern of initial
increase (day1) and decline to baseline levels by day 7
following 20 μg CNP exposure. Among them were:
IL1B, MCP1/CCL2, MIP1/CCL4, MMP9, MCP3/CCL7,
IP10/CXCL10, MPO, MIP2/CXCL2, IL6, GM-CSF/
CSF2, MIP1-gamma/CCL9, GCP-2/CXCL5, TIMP1,
FGA, MCP-5/CCL12, KC/CXCL1. As evident from the
list, the major PMN recruiters CXCL1, 2, 5 and 10 were
down regulated at day 7 compared to day 1 reflecting
the phenotypic observation of an obvious decline in
PMN numbers until day 7 (Figure 3).
Figure 1 Bronchoalveolar lavage fluid (BAL) cell differentials and protein concentration. Dose dependent influx and time dependent
resolution of (a) polymorphonuclear leukocytes (PMN), (b) macrophages, and (c) lymphocytes in the BAL following intratracheal (i.t.) instillationo f
carbon nanoparticles particles in the JF1/Msf (JF1) mice (n = 7 animals/experimental group). Total protein concentration is provided in Figure 1d.
(**) Significantly different with respect to (w.r.t) both sham control and 5 μg exposed; (***) significantly different w.r.t 20 μg exposed at day1,
sham control and 5 μg exposed; p ≤ 0.05.
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markers in the lung homogenate which showed an
initial shoot up and remained at elevated levels until day
7 thereby correlating in particular with increased BAL
cell differentials of alveolar macrophages and lympho-
cytes. These markers are IL1B, TNF, IL4, MDC/CCL22,
F7, and vWF (all except vWF are at/above sensitivity
level of detection). Their individual response pattern for
t h ed o s ea n dt h et i m er e s p o n s ei ss h o w ni nF i g u r e4 .
Interestingly IL4 in spite of not exhibiting an obvious
dose response was detected at significantly higher levels
at day 7 compared to sham, 5 μga n d2 0μg/day1 and
day 3. A detailed list of each of the 62 markers is pro-
vided in Additional File 1, Table S1.
BAL compartment
For BAL, only markers detected at/above sensitivity level
(see methods, n = 4 BAL samples were pooled/experi-
mental group) were considered. This were 23 out of 62
markers as represented in the heatmap (Figure 3). With
respect to the dose response, these 23 markers can be
categorized in (i) BAL markers exhibiting increasing
levels from 20 μgt o5 0μg CNP/day1 being CCL22,
SPP1, CSF2, CXCL2, Lipocalin 2/LCN2, CCL2, CSF1,
CCL7 and THPO; (ii) BAL markers exhibiting saturation
at 20 μg/day1, i.e. comparable levels at 20 μg and 50 μg/
day1 being F3, IL1B, FGF2, F7, CCL3, CCL4, TNF, IL18,
I L 1 A ,V E G F A ,a n dM M P 9 ;a n d( i i i )B A Lm a r k e r s
(CXCL5, CCL9 and CD40L) exhibiting highest concen-
trations at 20 μg/day1 and lower ones at 50 μgd o s a g e
similar to lymphocyte numbers observed in BAL sam-
ples during the dose response study.
With respect to the time course, 19 of the 23 BAL
markers reached their baseline levels by day7 in 20 μg
samples. Four markers - CCL22, CXCL5, CCL9 and
MMP9 -exhibit a clear decline in concentration from
day 1 to day7 but were somewhat elevated (1.5-2.5 fold
higher) than baseline level on day 7.
Biological pathway analysis
We identified 6 markers (IL1B, TNF, IL4, MDC/CCL22,
F7, and vWF) which remainedi ne l e v a t e dc o n c e n t r a -
tions in the lung compartment (i.e. concentrations on
day 7 were significantly higher to both sham and 5 μg
but not significantly lower to 20 μg/24 h or 20 μg/72 h).
This can be associated with the delayed macrophage-
Figure 2 Dose dependent accumulation of carbon nanoparticle laden macrophages in the lung. Histopathological analysis of the paraffin
embedded JF1 lung sections (n = 4) showed a dose dependent accumulation of carbon nanoparticle laden macrophages (2a-e). (a) Sham/day1,
(b) 5 μg/day1, (c) 20 μg/day1, (d,e) 50 μg/day1; (magnification: 2a-d:10×, 2e:40×).
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formed an extensive literature study which revealed a
close interaction between these markers which was also
observed by an analysis with the Ingenuity pathway soft-
ware. Known functions associated with the six marker
p r o t e i n sa r ea i r w a yi n f l a m m ation, activation of macro-
phages and recruitment of lymphocytes (Figure 5).
Discussion
Previously we observed large variation in pulmonary
function among inbred mouse strains [17,18,27] and
found that C3H/HeJ (C3) and JF1/Msf (JF1) to be the
most divergent strains. In comparison to C3, JF1 mice
have smaller, less compliant lungs with large conducting
airway volumes and distinct morphological differences,
like small alveolar dimensions. In JF1, total lung capacity
(TLC, female) is 60% to that of C3, the static lung com-
pliance is only less than half to that in C3, and the contri-
bution of airway volume to TLC is 1.5 times more in JF1
than C3 [18]. The mean alveolar chord length is also
smaller in JF1 compared to C3 [28]. Alveolar surface area
being the site of immediate interaction is however similar
among JF1 and C3 [28] (Table 1). Since lung size in mice
s h o w so n l yam o d e r a t ec o r r e l a t i o nt ob o d yw e i g h t[ 1 8 ]
and the alveolar surface area does not differ among C3
and JF1 we decided to use the same CNP dosage for both
strains to assess their acute inflammatory response and
its resolution.
Pulmonary response to CNP in JF1 mice
The dose response of JF1 to CNP exposure was character-
ized by a marked PMN cell influx (up to 25-fold induc-
tion) at day 1 reaching a saturation level already after
instillation of 20 μg CNP whereas at that time point no
considerable macrophage recruitment into the alveolar
space occurred. The marked influx of PMNs was asso-
ciated with a number of elevated inflammatory cytokine
levels, such as CXCL1, 2, 5, 10, CSF2, IL1B, CCL2, CCL7,
TNF in lung tissue and partly also in BAL fluid (Figure 3).
These cytokines are well known to be involved in PMN
recruitment, [29]. Also extracellular matrix protecting pro-
teins (TIMP1) and degrading enzymes (MMP9) were con-
siderably induced. Typically, the acute inflammatory
response to CNP is characterized by recruitment of PMN
Figure 3 Heatmap representation of protein concentration levels in lung homogenate and bronchoalveolar lavage (BAL) following
intratracheal instillation of carbon nanoparticles in JF1/Msf mice. Shown are normalized data (highest value is set to “1”) for dose or time
response. Red color indicates increasing concentrations. Protein symbols and relative expression day7/day1 (in %) are indicated.
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Page 7 of 11Figure 4 Time course response markers in the lung homogenate following intratracheal (i.t.) instillation of carbon nanoparticles (CNP)
in JF1/Msf (JF1) mice. (a-f) Shown are markers with remaining elevated levels at day 7 after an initial significant induction at day1 (except IL4)
in response to 20 μg i.t. instillation of CNP. F7: Factor VII; IL1B: Interleukin-1beta; IL4: Interleukin-4; MDC/CCL22: Macrophage-Derived Chemokine;
TNF: Tumor Necrosis Factor-alpha; vWF: von Willebrand Factor; (**) Significantly different with respect to (w.r.t) both sham control and 5 μg dose;
(†) significantly different w.r.t 20 μg exposed at day1; (***) significantly different w.r.t 20 μg at day1, 5 μg and sham control. p ≤ 0.05; (n = 4
animals/experimental group).
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cell numbers after 3 to 7 days. However, detection of 5
times higher than baseline levels of PMN on day 7 after
CNP exposure indicates that the ongoing resolution pro-
cess is not complete at this time point in JF1 mice. The
impaired resolution of inflammation is further supported
by the delayed influx of macrophages (2-fold increased)
and considerable recruitment of lymphocytes (35-times
induced) into the airway lumen one week after treated
with 20 μg CNP. From the panel of protein markers ana-
lysed we have detected 6 markers - IL1B, IL4, MDC/
CCL22, TNF, F7, and vWF - which remained elevated up
to day 7. Our pathway analysis revealed a close interaction
between these markers (Figure 5) and their implication in
airway inflammation, activation of macrophages and
recruitment of lymphocytes.
The proinflammatory markers TNF and IL1B remained
elevated between day 1 and day 7. Elevated levels of IL1B
and TNF in lung tissue are consistent with the observed
impaired clearance of PMN from the lungs [30] resulting
in the higher than baseline PMN levels on day 7. Due to
their pleotrophic proinflammatory properties it is plausi-
ble that they are also involved in elevated numbers of
alveolar macrophages detectable at day 7. In this context
it is interesting to note that the cytokine IL4 exhibited
increased levels either at high dosage (50 μg CNP) on day
1o ra tt h e2 0μg dose on day 7. IL-4 is considered to be
involved in chronic inflammatory responses [31] and is
deeply involved in allergic airway inflammation, in regu-
lation of lymphocyte differentiation of naïve helper
T-cells to Th2 cells [32] as well as modulating the TNF
mediated growth and differentiation of dendritic cells
(DC) [33,34]. IL4 favors the polarisation of macrophages
to the M2a type [31]. The macrophage derived chemo-
kine CCL22 is a CC chemokine produced in a constitu-
tive way by M2 macrophages [31], but also by dendritic
cells (DC) and by activated B lymphocytes. CCL22 is che-
motactic for DC, natural killer cells and activated T lym-
phocytes [35-37]. Taken together, our study shows that
JF1 exhibit an impaired resolution of inflammation in
response to CNP exposure. The delayed clearance of
many pro-inflammatory cytokines which peaked at day 1
after CNP exposure together with still increased levels of
IL1B, TNF, IL4, CCL22 could be associated with the
delayed clearance of PMNs and increased numbers of
macrophage and lymphocytes in the JF1 lungs detected
one week after CNP exposure.
Comparison of pulmonary responses to CNP in C3 and
JF1 mice
C3 mice were previously subjected to an identical expo-
sure protocol as JF1 mice [21]. Although C3 mice showed
a strong inflammatory response to CNP as evidenced by
influx of PMNs into the alveolar space at the highest
dose (~40 fold induction at 50 μgC N P )a n dt h ei n d u c -
tion of most of the biomarkers at day 1 (49 out of 62
were upregulated) they were able to completely resolve
the PMN influx within 7 days. Moreover, in C3 mice cell
numbers of macrophages and lymphocytes were not
affected (Table 2). A defense/homeostasis pathway was
activated, with IL1B/IL18, EDN1, FGF2, and VEGF [21]
as the major players. Table 2 illustrates the distinct differ-
ent responses to CNP in C3 and JF1 mice for BAL cells
and selected biomarkers being either elevated at day 7 in
C3 or JF1 mice. However, in response to CNP, many of
the inflammatory biomarkers which were initially upre-
gulated and remained elevated in C3 were not affected in
Figure 5 Pathway analysis of proteins detected at elevated
concentrations during time course analysis in lung following
intratracheal instillation of 20 μg carbon nanoparticles (CNP).
At day 7 when PMN levels were 5 times higher compared to
baseline and a sudden influx of lymphocytes and macrophages was
detected, Interleukin-1beta (IL1B), Tumor necrosis factor-alpha (TNF),
Factor VII (F7), Interleukin-4 (IL4), Macrophage-derived chemokine
(MDC/CCL22) and von Willebrand Factor (vWF) remained at
significantly elevated concentrations compared to their baseline
levels. The predicted molecular network indicates the role of these
markers in airway inflammation, recruitment of lymphocytes and
activation of macrophages. Shown are the extracellular space, part
of the cell membrane and published interactions are indicated by
arrows (line thickness represents the number of references).
Table 1 Comparison of lung characteristics between
female C3H/HeJ and JF1/Msf mice.
Parameter C3H/HeJ JF1/Msf Reference
Body weight (g) 22.4 ± 0.6 16.5 ± 0.4 [18]
Total Lung Capacity (TLC)(μl) 1443 ± 29 874 ± 17 [17,18]
Static Lung Compliance (sCL)
(cmH2O/ml)
84.8 ± 3.6 35.5 ± 2.2 [17,18]
Dead Space (VD) volume (%) 15.8 ± 0.3 22.1 ± 0.5 [17,18]
Mean alveolar Chord length (μm) 69.2 ± 14.8 48.5 ± 5.5 [28]
Alveolar surface area (cm
2) 847 ± 70 906 ± 102 [28]
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F3, EDN, CRP, APCS. On the other hand, in JF1 levels of
TNF, IL4, CCL22, F7, vWF remained elevated at day7
which were though initially upregulated in C3 but most
of them reached baseline levels at day 7. In particular, in
JF1 mice elevated levels of IL1B and TNF were detected
but not IL18 which was involved in the induction of
EDN1/FGF2/VEGF homeostatic pathway in C3. This
may in part explain the deleterious effects of CNP in JF1
mice. SOD3 is the main extracellular antioxidant enzyme
of the lung. JF1 mice have 2-3 fold lower superoxide dis-
mutase 3 (Sod3) transcript, protein and also activity levels
in the lungs compared to C3 [16,38]. Interestingly, Laur-
ila at al. [39] showed that SOD3 significantly reduces
inflammatory cell migration of mononuclear cells after
ischemic damage by regulating adhesion molecules and
cytokine expression, among them TNF, which stayed ele-
vated in JF1. Hence, it is reasonable to assume that deple-
tion of SOD3 can alter the response to particle mediated
oxidative stress. It may be plausible that the difference in
the levels of superoxide dismutase 3 in the lungs of
between C3 and JF1 influence the different response pat-
tern to CNP.
Conclusion
JF1 exhibit an impaired resolution of inflammation in
response to CNP exposure evidenced by a delayed clear-
ance of PMNs from the lungs and an influx of mono-
nulclear cells into the lungs one week after exposure. At
the molecular level, this phenotype was associated with
elevated levels of IL1B, TNF, IL4, CCL22, and the lack
of establishing the defense/homeostasis pathway as
recently proposed for C3 mice [21] which involves the
upregulation of IL18, EDN1, FGF2, and VEGF. This sug-
gests an increased susceptibility of JF1 to extrinsic
insults and a potential disposition to continuing of
inflammatory processes. Therefore these explorative stu-
dies identified plausible molecular pathways causing the
different response to CNP in JF1 and C3 mice. Further
pathway directed investigations are required to improve
our understanding on the genetic and molecular basis of
CNP induced inflammatory response.
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